Provided by Tiger Trade Technology Pte. Ltd.

Alumis Inc.

9.88
+0.08000.82%
Volume:1.93M
Turnover:19.32M
Market Cap:1.27B
PE:-2.60
High:10.55
Open:10.55
Low:9.65
Close:9.80
52wk High:31.35
52wk Low:3.76
Shares:129.00M
Float Shares:104.00M
Volume Ratio:0.76
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8005
EPS(LYR):-2.8616
ROE:-93.65%
ROA:-45.34%
PB:2.82
PE(LYR):-3.45

Loading ...

Alia Mentis Files Share Capital Increase After Greenshoe Exercise

TIPRANKS
·
Jul 28

Analysts Offer Insights on Healthcare Companies: Alumis Inc. (ALMS) and AbCellera Biologics (ABCL)

TIPRANKS
·
Jul 16

Alumis Inc. (ALMS) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Jul 10

Top Alumis Insider Makes Notable Move With Significant Stock Sale

TIPRANKS
·
Jul 09

Alumis Chief Legal Officer Sanam Pangali Disposes of Common Shares Worth $140,000

Reuters
·
Jul 09

Alumis Shareholders Reelect Directors and Ratify Auditor

TIPRANKS
·
Jul 03

Alumis Holds Annual Shareholder Meeting

Reuters
·
Jul 03

Alumis (ALMS) Joins Growth Indices, Is The Stock Overvalued?

Simply Wall St.
·
Jul 03

Analysts Conflicted on These Healthcare Names: Alumis Inc. (ALMS), Glaukos (GKOS) and Regeneron (REGN)

TIPRANKS
·
Jul 01

Alumis Highlights TYK2 Strategy in Updated Investor Presentation

TIPRANKS
·
Jun 29

Alumis management to meet with Cantor

TIPRANKS
·
Jun 27

Maplight Therapeutics Names Martin Babler, Troy Cox to Board of Directors

Reuters
·
Jun 24

Alumis rises 10.3%

TIPRANKS
·
Jun 13

Alumis Is Maintained at Buy by Chardan Capital

Dow Jones
·
May 19

Chardan Raises Price Target on Alumis to $40 From $38, Keeps Buy Rating

MT Newswires Live
·
May 19

Alumis announces annual shareholder meeting

Reuters
·
May 19

Should Alumis’ (ALMS) Envudeucitinib-Centric Strategy After Q1 Losses Require Action From Investors?

Simply Wall St.
·
May 17

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Amid Oil Surge, Higher Yields, Geopolitical Uncertainty

MT Newswires Live
·
May 15

Alumis Is Maintained at Overweight by Wells Fargo

Dow Jones
·
May 15

Alumis price target raised to $39 from $38 at Morgan Stanley

TIPRANKS
·
May 15